Related Experiment Videos
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components
1Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Università degli Studi di Messina, Italy.
Infection and Immunity
|June 1, 1997
Summary
Cryptococcus neoformans components stimulate interleukin-6 (IL-6) production in human blood. This immune response, independent of tumor necrosis factor alpha, may have implications for human immunodeficiency virus replication.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen.
- Interleukin-6 (IL-6) is a key cytokine in immune responses.
- The interaction between C. neoformans and host immune cells is not fully understood.
Purpose of the Study:
- To investigate the ability of purified Cryptococcus neoformans capsular components to induce IL-6 production.
- To determine the relative potencies of different capsular components in stimulating IL-6 release.
- To elucidate the cellular and molecular requirements for IL-6 induction by C. neoformans.
Main Methods:
- Human whole blood was stimulated with purified capsular products of C. neoformans.
- IL-6 production was quantified using appropriate assays.
- The role of tumor necrosis factor alpha, monocytes, and plasma in IL-6 production was assessed.
Main Results:
- Mannoproteins were the most potent stimulators of IL-6 release, followed by galactoxylomannan and glucuronoxylomannan, with alpha(1-3)glucan showing the least potency.
- IL-6 production was independent of tumor necrosis factor alpha.
- The presence of monocytes and plasma was required for significant IL-6 production.
Conclusions:
- Purified capsular components of Cryptococcus neoformans can induce IL-6 production in human whole blood.
- The potency of capsular components varies, with mannoproteins being the strongest inducers.
- The findings highlight a potential mechanism linking fungal infection to immune dysregulation and may have clinical relevance for human immunodeficiency virus (HIV) infection.